| pubmed-article:10550159 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10550159 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:10550159 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:10550159 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:10550159 | lifeskim:mentions | umls-concept:C0014582 | lld:lifeskim |
| pubmed-article:10550159 | lifeskim:mentions | umls-concept:C0876994 | lld:lifeskim |
| pubmed-article:10550159 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:10550159 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:10550159 | pubmed:dateCreated | 2000-1-18 | lld:pubmed |
| pubmed-article:10550159 | pubmed:abstractText | To evaluate the incidence of clinically relevant cardiac toxicity after treatment with epirubicin/paclitaxel-containing regimens in patients with metastatic breast cancer and to identify high-risk patients in whom the benefit of chemotherapy may be negated by the occurrence of congestive heart failure (CHF). | lld:pubmed |
| pubmed-article:10550159 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10550159 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10550159 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10550159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10550159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10550159 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10550159 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:10550159 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:Del TaccaMM | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:SalvadoriBB | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:DonathRR | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:YonemitsuHH | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:DanesiRR | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:BruzziPP | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:GennariAA | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:OrlandiniCC | lld:pubmed |
| pubmed-article:10550159 | pubmed:author | pubmed-author:BengalaCC | lld:pubmed |
| pubmed-article:10550159 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10550159 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:10550159 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10550159 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10550159 | pubmed:pagination | 3596-602 | lld:pubmed |
| pubmed-article:10550159 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:meshHeading | pubmed-meshheading:10550159... | lld:pubmed |
| pubmed-article:10550159 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10550159 | pubmed:articleTitle | Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors. | lld:pubmed |
| pubmed-article:10550159 | pubmed:affiliation | Divisione di Oncologia Medica, Dipartimento di Oncologia, Ospedale Santa Chiara e Universita, Pisa, Italy. a.gennari@do.med.unipi.it | lld:pubmed |
| pubmed-article:10550159 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10550159 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10550159 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10550159 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10550159 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10550159 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10550159 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10550159 | lld:pubmed |
